Cargando…

Circular RNA atlas in osteoclast differentiation with and without alendronate treatment

BACKGROUND: Alendronate (AL) is the most widely used bisphosphonate in the treatment of osteoporosis (OP). However, the role of circular RNAs (circRNAs) in the treatment of OP with AL remains unclear. METHODS: In this study, we showed that osteoclast (OC) precursors (OPCSs) could be induced into OCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jianbiao, Ma, Shaofeng, Zhu, Cong, Chen, Changqing, Lin, Weibin, Lin, Canbin, Huang, Guofeng, Ding, Zhenqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331147/
https://www.ncbi.nlm.nih.gov/pubmed/32611361
http://dx.doi.org/10.1186/s13018-020-01722-6
_version_ 1783553263160786944
author Lin, Jianbiao
Ma, Shaofeng
Zhu, Cong
Chen, Changqing
Lin, Weibin
Lin, Canbin
Huang, Guofeng
Ding, Zhenqi
author_facet Lin, Jianbiao
Ma, Shaofeng
Zhu, Cong
Chen, Changqing
Lin, Weibin
Lin, Canbin
Huang, Guofeng
Ding, Zhenqi
author_sort Lin, Jianbiao
collection PubMed
description BACKGROUND: Alendronate (AL) is the most widely used bisphosphonate in the treatment of osteoporosis (OP). However, the role of circular RNAs (circRNAs) in the treatment of OP with AL remains unclear. METHODS: In this study, we showed that osteoclast (OC) precursors (OPCSs) could be induced into OCs with macrophage colony-stimulating factor (MCSF) and receptor activator of nuclear factor-κB ligand (RANKL) treatment. Subsequently, the OCs were treated with AL. OC differentiation-related biomarkers including RANK, tartrate-resistant acid phosphatase (TRAP), and cathepsin K (CTSK) were analyzed with TRAP staining, quantitative real-time (qPCR), and western blotting. Differentially expressed circRNAs (DECs) were identified among the OPCS, OC, and OC + AL groups. In addition, the expression levels of 10 DECs related to OC differentiation were verified by qPCR. RESULTS: TRAP staining showed that MCSF and RANKL treatment effectively induced OPCSs to differentiate into OCs. In addition, qPCR and western blot analysis revealed that the three biomarkers of OC (RANK, TRAP, and CTSK) were expressed significantly more in the OC group than those in the OPCS group. In contrast, the mRNA and protein expression levels of these three biomarkers decreased significantly in OCs treated with AL compared with those non-treated OCs. GO analysis of the DECs in the OPCS group vs. the OC group revealed that their functions were mainly related to cell, cell part, binding, and single-organism terms. KEGG analysis of the top 20 DECs in a comparison between the OPCS and OC groups showed that genes involved in mitogen-activated protein kinase signaling were the most common. Results of functional analyses of DECs in an OC vs. OC + AL comparison were similar to those in the OPCS vs. OC comparison. Finally, qPCR showed that, in the OC + AL vs. OC group comparison, the expression levels of seven and three DECs significantly decreased and increased, respectively. CONCLUSIONS: Having successfully induced OPCSs to differentiate into OCs, we showed that AL suppresses the differentiation of OPCS into OC and that 10 DECs were involved in the regulation of this process. This indicates that these DECs might be important to the treatment of OP.
format Online
Article
Text
id pubmed-7331147
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73311472020-07-06 Circular RNA atlas in osteoclast differentiation with and without alendronate treatment Lin, Jianbiao Ma, Shaofeng Zhu, Cong Chen, Changqing Lin, Weibin Lin, Canbin Huang, Guofeng Ding, Zhenqi J Orthop Surg Res Research Article BACKGROUND: Alendronate (AL) is the most widely used bisphosphonate in the treatment of osteoporosis (OP). However, the role of circular RNAs (circRNAs) in the treatment of OP with AL remains unclear. METHODS: In this study, we showed that osteoclast (OC) precursors (OPCSs) could be induced into OCs with macrophage colony-stimulating factor (MCSF) and receptor activator of nuclear factor-κB ligand (RANKL) treatment. Subsequently, the OCs were treated with AL. OC differentiation-related biomarkers including RANK, tartrate-resistant acid phosphatase (TRAP), and cathepsin K (CTSK) were analyzed with TRAP staining, quantitative real-time (qPCR), and western blotting. Differentially expressed circRNAs (DECs) were identified among the OPCS, OC, and OC + AL groups. In addition, the expression levels of 10 DECs related to OC differentiation were verified by qPCR. RESULTS: TRAP staining showed that MCSF and RANKL treatment effectively induced OPCSs to differentiate into OCs. In addition, qPCR and western blot analysis revealed that the three biomarkers of OC (RANK, TRAP, and CTSK) were expressed significantly more in the OC group than those in the OPCS group. In contrast, the mRNA and protein expression levels of these three biomarkers decreased significantly in OCs treated with AL compared with those non-treated OCs. GO analysis of the DECs in the OPCS group vs. the OC group revealed that their functions were mainly related to cell, cell part, binding, and single-organism terms. KEGG analysis of the top 20 DECs in a comparison between the OPCS and OC groups showed that genes involved in mitogen-activated protein kinase signaling were the most common. Results of functional analyses of DECs in an OC vs. OC + AL comparison were similar to those in the OPCS vs. OC comparison. Finally, qPCR showed that, in the OC + AL vs. OC group comparison, the expression levels of seven and three DECs significantly decreased and increased, respectively. CONCLUSIONS: Having successfully induced OPCSs to differentiate into OCs, we showed that AL suppresses the differentiation of OPCS into OC and that 10 DECs were involved in the regulation of this process. This indicates that these DECs might be important to the treatment of OP. BioMed Central 2020-07-01 /pmc/articles/PMC7331147/ /pubmed/32611361 http://dx.doi.org/10.1186/s13018-020-01722-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lin, Jianbiao
Ma, Shaofeng
Zhu, Cong
Chen, Changqing
Lin, Weibin
Lin, Canbin
Huang, Guofeng
Ding, Zhenqi
Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
title Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
title_full Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
title_fullStr Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
title_full_unstemmed Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
title_short Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
title_sort circular rna atlas in osteoclast differentiation with and without alendronate treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331147/
https://www.ncbi.nlm.nih.gov/pubmed/32611361
http://dx.doi.org/10.1186/s13018-020-01722-6
work_keys_str_mv AT linjianbiao circularrnaatlasinosteoclastdifferentiationwithandwithoutalendronatetreatment
AT mashaofeng circularrnaatlasinosteoclastdifferentiationwithandwithoutalendronatetreatment
AT zhucong circularrnaatlasinosteoclastdifferentiationwithandwithoutalendronatetreatment
AT chenchangqing circularrnaatlasinosteoclastdifferentiationwithandwithoutalendronatetreatment
AT linweibin circularrnaatlasinosteoclastdifferentiationwithandwithoutalendronatetreatment
AT lincanbin circularrnaatlasinosteoclastdifferentiationwithandwithoutalendronatetreatment
AT huangguofeng circularrnaatlasinosteoclastdifferentiationwithandwithoutalendronatetreatment
AT dingzhenqi circularrnaatlasinosteoclastdifferentiationwithandwithoutalendronatetreatment